Amino-terminal pro-brain natriuretic peptide and brain natriuretic peptide measurements under various detection conditions in patients with chronic heart failure.
- Author:
Wei-jia WANG
1
;
Xiu-ming ZHANG
;
Qian WANG
;
Dong-mei WEN
;
Neng-liang OUYANG
;
Ya-li CUI
;
Fei LI
Author Information
- Publication Type:Journal Article
- MeSH: Electrochemical Techniques; methods; Heart Failure; blood; diagnosis; Humans; Immunoassay; methods; Luminescent Measurements; methods; Natriuretic Peptide, Brain; blood; Peptide Fragments; blood; Sensitivity and Specificity; Specimen Handling; methods; standards
- From: Chinese Journal of Cardiology 2011;39(8):695-699
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo find the potential interference factors for the detection of NT-proBNP and BNP in patients with chronic heart failure.
METHODSEP15-A2 issued by Clinical and Laboratory Standards Institute (CLSI) was employed to compare the precision and accuracy of commercial NT-proBNP and BNP analyzer electrochemiluminescence immunoassay system Cobas E601 and chemiluminescence system ADVIA Centaur. Moreover, NT-proBNP and BNP were detected in different time interval and in different interfered sampling conditions (haematolysis, choloplania, lipemia). NT-proBNP and BNP of 203 patients with heart failure or heart failure complicated with acute cerebral infarction were analyzed to find the deviation caused by patients' endogenous factors.
RESULTSThe precision and accuracy were comparable for NT-proBNP and BNP detection using Cobas E601 and ADVIA Centaur (total-CV below 2.9% and 3.5%, the deviation from definite value below 2.38% and 3.91%). The most suitable sample type for NT-proBNP and BNP detection was serum and EDTA-anticoagulant plasma. The detection results of NT-proBNP and BNP were comparable for at least 120 min post sampling and not affected by Hb (2 g/L), DB (428 µmol/L) and chyle (2000 FIU). NT-proBNP was significantly higher in heart failure patients complicated with cerebral infarction (P = 0.003) than in heart failure patients. BNP was significantly higher in heart failure grade III patients complicated with cerebral infarction (P < 0.01).
CONCLUSIONSCobas E601 and ADVIA Centaur supplied satisfactory detection of NT-proBNP and BNP in patients with chronic heart failure with strong anti-interference capacity. The diagnostic value of NT-proBNP and BNP for chronic heart failure should be analyzed objectively in the presence of complicating diseases.
